FDA NAMs-Aligned
Predictive Toxicology
AI-Driven Analytics
Human-Centric Models
Digital Organ Twins
Quantum-Enhanced Modeling
Patented Technology
Precision Disease Models
Reduced Animal Testing
FDA NAMs-Aligned
Predictive Toxicology
AI-Driven Analytics
Human-Centric Models
Digital Organ Twins
Quantum-Enhanced Modeling
Patented Technology
Precision Disease Models
Reduced Animal Testing
Dr. Soja is an eminent deep-tech innovator in the field of 3D bioprinting, microfluidics, and biomedical engineering. She earned her PhD in biotechnology with summa cum laude distinction from DBT-RGCB, India’s premier biotechnology institute, and pursued advanced training at New York University and pharma industry.
Dr. Soja is the pioneer scientist who established the region’s first state-of-the-art 3D bioprinting research laboratory at NYU Abu Dhabi, setting a benchmark in the field of bio-convergent technologies. Her passion for advancing human-centric drug testing platforms began over 15 years ago at Zydus Cadila, while leading projects to reduce animal use in drug development. Dr. Soja has multiple patents, grants, and high-impact publications